Poolbeg Pharma trial to feature in major CRS research programme

DELFI Diagnostics presents preliminary data showing potential for blood-based lung cancer detection in non-smoking population

Natera acquires Foresight Diagnostics to expand MRD capabilities

FDA clears Bristol Myers Squibb's Breyanzi as first CAR T therapy for relapsed or refractory marginal zone lymphoma

OncoHost named Gold Winner in 2025 Merit Awards for Healthcare

Innovent Biologics and Takeda sign global strategic partnership

TransThera publishes clinical results from US-based Phase 2 trial of tinengotinib in CCA

Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase

OncoPrecision's ONC001 data selected for presentation at 67th ASH Annual Meeting and Exposition

Immedica gets UAE approval for Zepzelca maintenance treatment

HEALTH Magazine's Beyond Pink Event Brings Experts and Survivors Together to Spotlight Women's Health in the UAE

Imugene Ltd enters co-development collaboration with JW Therapeutics (Shanghai)

Sichuan Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy clinical study results published in Annals of Oncology

Mendus reports trial follow-up data supporting potential of vididencel in high-risk ovarian cancer

SK Biopharmaceuticals signs licence agreement with Wisconsin Alumni Research Foundation